Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALLBlood, 2021-09, Vol.138 (11), p.948-958 [Peer Reviewed Journal]2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020010144 ;PMID: 33895809Full text available |
|
2 |
Material Type: Article
|
Joint Analyses of Serum Proteins and Circulating Tumor DNA Improves Risk Assessment and Subtype Stratification in Large B-Cell LymphomasBlood, 2023-11, Vol.142 (Supplement 1), p.3015-3015 [Peer Reviewed Journal]ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-177849Full text available |
|
3 |
Material Type: Article
|
p53 Mutant Independently Impacts Risk: Analysis of Deletion 5q, Lower-Risk Myelodysplastic Syndromes (MDS) Patients Treated with Lenalidomide (LEN) in the MDS-004 StudyBlood, 2014-12, Vol.124 (21), p.414-414 [Peer Reviewed Journal]2014 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V124.21.414.414Full text available |
|
4 |
Material Type: Article
|
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Blood, 2007-02, Vol.109 (3), p.926-935 [Peer Reviewed Journal]2007 American Society of Hematology ;2007 INIST-CNRS ;2007 by The American Society of Hematology 2007 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2006-01-024729 ;PMID: 17003380Full text available |
|
5 |
Material Type: Article
|
Development of a Risk Assessment Model for Cardiac Injury in Patients Newly Diagnosed with Acute Myeloid Leukemia Based on a Multicenter, Real-World Analysis in ChinaBlood, 2023-11, Vol.142 (Supplement 1), p.5855-5855 [Peer Reviewed Journal]ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-174050Full text available |
|
6 |
Material Type: Article
|
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow TransplantationBlood, 2013-02, Vol.121 (6), p.1059-1064 [Peer Reviewed Journal]2013 American Society of Hematology ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-07-445965 ;PMID: 23247725Full text available |
|
7 |
Material Type: Article
|
Comparative Risk Assessment of Imatinib, Nilotinib and Dasatinib in Randomized Controlled Trials: A Meta-AnalysisBlood, 2017-12, Vol.130, p.2869-2869 [Peer Reviewed Journal]2017 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V130.Suppl_1.2869.2869Full text available |
|
8 |
Material Type: Article
|
The Analysis of Risk for Solitary Bone Plasmacytoma Rapidly Progressing to Multiple MyelomaBlood, 2021-11, Vol.138 (Supplement 1), p.4750-4750 [Peer Reviewed Journal]2021 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2021-145024Full text available |
|
9 |
Material Type: Article
|
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantationBlood, 2008-11, Vol.112 (9), p.3574-3581 [Peer Reviewed Journal]2008 American Society of Hematology ;2009 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2008-02-140095 ;PMID: 18606875Full text available |
|
10 |
Material Type: Article
|
Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant PatientsBlood, 2023-11, Vol.142 (Supplement 1), p.3725-3725 [Peer Reviewed Journal]ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-189629Full text available |
|
11 |
Material Type: Article
|
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumBlood, 2008-04, Vol.111 (8), p.4029-4038 [Peer Reviewed Journal]2008 American Society of Hematology ;2008 INIST-CNRS ;2008 by The American Society of Hematology 2008 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2007-10-119974 ;PMID: 18263783Full text available |
|
12 |
Material Type: Article
|
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysisBlood, 2017-10, Vol.130 (15), p.1757-1759 [Peer Reviewed Journal]2017 American Society of Hematology ;2017 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-06-791756 ;PMID: 28768627Full text available |
|
13 |
Material Type: Article
|
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapyBlood, 2006-05, Vol.107 (10), p.3832-3840 [Peer Reviewed Journal]2006 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2005-09-3600 ;PMID: 16410446Full text available |
|
14 |
Material Type: Article
|
A Novel, Clinically Adaptable Comorbidity Assessment Tool for Non-Hodgkin Lymphoma (NHL), the Three-Factor Risk Estimate Scale (TRES): Analysis of 40,000 Older Adults Enrolled in SEER-MedicareBlood, 2022-11, Vol.140 (Supplement 1), p.1924-1925 [Peer Reviewed Journal]2022 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2022-159632Full text available |
|
15 |
Material Type: Article
|
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trialBlood, 2013-05, Vol.121 (20), p.4056-4062 [Peer Reviewed Journal]2013 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-11-468348 ;PMID: 23535063Full text available |
|
16 |
Material Type: Article
|
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factorsBlood, 2000-03, Vol.95 (5), p.1588-1593 [Peer Reviewed Journal]2000 American Society of Hematology ;2000 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V95.5.1588.005k38_1588_1593 ;PMID: 10688812Full text available |
|
17 |
Material Type: Article
|
Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to ChemotherapyBlood, 2019-11, Vol.134 (Supplement_1), p.3642-3642 [Peer Reviewed Journal]2019 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2019-129901Full text available |
|
18 |
Material Type: Article
|
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trialBlood, 2012-10, Vol.120 (14), p.2826-2835 [Peer Reviewed Journal]2012 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-06-435669 ;PMID: 22875911Full text available |
|
19 |
Material Type: Article
|
Oncology Providers Ability to Prognosticate Patient Outcomes: An Analysis of the Survey on Provider Assessment of Risk (SPAR) StudyBlood, 2015-12, Vol.126 (23), p.5635-5635 [Peer Reviewed Journal]2015 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.V126.23.5635.5635Full text available |
|
20 |
Material Type: Article
|
The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studiesBlood, 2012-03, Vol.119 (10), p.2392-2400 [Peer Reviewed Journal]2012 American Society of Hematology ;2015 INIST-CNRS ;2012 by The American Society of Hematology 2012 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-10-383448 ;PMID: 22251481Full text available |